Because we have seen that this progressive vasoconstriction: (1) occurs later than 4 h; (2) is relieved by ACE2 mediated mechanisms; and (3) is MasR dependent, we have now identified ACE2 as a powerful and novel approach to prevent stroke progression mediated by post-occlusive vasoconstriction. The gene discussed is ACE2; the disease is stroke disorder.